Back to search

Belgium· BE-AMP-SAM485084-00

Genvoya 150 mg - 150 mg - 200 mg - 10 mg

A emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat product containing cobicistat, registered in Belgium by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR18

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedGenvoya 150 mg - 150 mg - 200 mg - 10…ATCJ05AR18REGISTER NO.BE-AMP-SAM485084-00PACKS LISTED6CHECKEDSeptember 26, 2026

Where it is registered

Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR18 (emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat · ATC J05AR18

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Cobicistat
Manufacturer
Gilead Sciences Ireland UC
Country
Belgium (BE)
ATC code
J05AR18
ATC class
Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 6

3 priced
  • be_apb
    4201877
    EUR 858.71
  • be_apb
    4239745
    EUR 858.71
  • be_apb
    3381456
    EUR 858.71
  • be_apb
    7715758
  • be_apb
    7729841
  • be_apb
    7729494

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Tybost
  • Liechtenstein · Tybost
  • Norway · Tybost

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b5a6b76b-4d7c-4d5b-9ce0-0034cae273d5
GET /v1/drugs/b5a6b76b-4d7c-4d5b-9ce0-0034cae273d5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Genvoya 150 mg - 150 mg - 200 mg - 10 mg",
  "name_fr": "Genvoya 150 mg - 150 mg - 200 mg - 10 mg",
  "name_nl": "Genvoya 150 mg - 150 mg - 200 mg - 10 mg",
  "amp_code": "SAM485084-00",
  "strengths": [
    "150.0000",
    "150.0000",
    "10.0000",
    "200.0000",
    "60.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Cobicistat",
    "Elvitegravir",
    "Tenofovir Alafenamide Fumarate",
    "Tenofovir Alafenamide",
    "Emtricitabine",
    "Lactose",
    "Sodium Laurilsulfate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Emtricitabine, Tenofovir Alafenamide, Elvitegravir and Cobicistat",
  "authorisation_numbers": [
    "EU/1/15/1061/001",
    "EU/1/15/1061/002"
  ]
}

See everything about emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.